Ignite Creation Date:
2024-05-06 @ 9:55 AM
Last Modification Date:
2024-10-26 @ 12:22 PM
Study NCT ID:
NCT03113760
Status:
COMPLETED
Last Update Posted:
2024-02-02
First Post:
2017-02-28
Brief Title:
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency
Sponsor:
Organization:
AB2 Bio Ltd